Mohammad Alsuwaidan
Mohammad Alsuwaidan
Assistant Professor of Psychiatry, University of Toronto
Verified email at utoronto.ca - Homepage
Title
Cited by
Cited by
Year
Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions
RS McIntyre, DS Cha, JK Soczynska, HO Woldeyohannes, LA Gallaugher, ...
Depression and anxiety 30 (6), 515-527, 2013
4622013
Bipolar disorder and metabolic syndrome: an international perspective
RS McIntyre, M Danilewitz, SS Liauw, DE Kemp, HTT Nguyen, LS Kahn, ...
Journal of affective disorders 126 (3), 366-387, 2010
1912010
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus
JK Soczynska, SH Kennedy, HO Woldeyohannes, SS Liauw, ...
Neuromolecular medicine 13 (2), 93-116, 2011
1412011
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders
RS McIntyre, M Alsuwaidan, BI Goldstein, VH Taylor, A Schaffer, ...
Ann Clin Psychiatry 24 (1), 69-81, 2012
1232012
Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap
RS McIntyre, NL Rasgon, DE Kemp, HT Nguyen, CWY Law, VH Taylor, ...
Current diabetes reports 9 (1), 51-59, 2009
1202009
The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project
RS McIntyre, JZ Soczynska, HO Woldeyohannes, MT Alsuwaidan, ...
Comprehensive psychiatry 56, 279-282, 2015
1082015
Cracks and crevices: Globalization discourse and medical education
BD Hodges, JM Maniate, MA Martimianakis, M Alsuwaidan, C Segouin
Medical teacher 31 (10), 910-917, 2009
962009
The association between conventional antidepressants and the metabolic syndrome
RS McIntyre, KY Park, CWY Law, F Sultan, A Adams, MT Lourenco, ...
CNS drugs 24 (9), 741-753, 2010
902010
Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders?
RS McIntyre, HA Kenna, HT Nguyen, CWY Law, F Sultan, ...
Advances in therapy 27 (2), 63-80, 2010
732010
The prevalence and illness characteristics of DSM-5-defined “mixed feature specifier” in adults with major depressive disorder and bipolar disorder: results from the …
RS McIntyre, JK Soczynska, DS Cha, HO Woldeyohannes, RS Dale, ...
Journal of affective disorders 172, 259-264, 2015
692015
The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders
RS McIntyre, AM Powell, O Kaidanovich-Beilin, JK Soczynska, ...
Behavioural brain research 237, 164-171, 2013
682013
A preclinical and clinical rationale for quetiapine in mood syndromes
RS McIntyre, JK Soczynska, HO Woldeyohannes, M Alsuwaidan, ...
Expert opinion on pharmacotherapy 8 (9), 1211-1219, 2007
682007
Exercise and bipolar disorder: a review of neurobiological mediators
MT Alsuwaidan, A Kucyi, CWY Law, RS McIntyre
Neuromolecular medicine 11 (4), 328, 2009
572009
The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project
RS McIntyre, JK Soczynska, SS Liauw, HO Woldeyohannes, E Brietzke, ...
The International Journal of Psychiatry in Medicine 43 (2), 165-177, 2012
542012
Advancing biomarker research: utilizing ‘Big Data’approaches for the characterization and prevention of bipolar disorder
RS McIntyre, DS Cha, JM Jerrell, W Swardfager, RD Kim, LG Costa, ...
Bipolar disorders 16 (5), 531-547, 2014
532014
Aerobic physical exercise as a possible treatment for neurocognitive dysfunction in bipolar disorder
A Kucyi, MT Alsuwaidan, SS Liauw, RS McIntyre
Postgraduate medicine 122 (6), 107-116, 2010
512010
The hepatic safety profile of duloxetine: a review
RS McIntyre, ZD Panjwani, HT Nguyen, HO Woldeyohannes, ...
Expert opinion on drug metabolism & toxicology 4 (3), 281-285, 2008
512008
The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder
RS McIntyre, HO Woldeyohannes, JK Soczynska, A Miranda, ...
Advances in therapy 27 (11), 828-836, 2010
402010
A pilot, open‐label, 8‐week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression
JK Soczynska, SH Kennedy, M Alsuwaidan, RB Mansur, M Li, ...
Bipolar disorders 19 (3), 198-213, 2017
272017
The effect of bipolar I disorder and major depressive disorder on workforce function
SH Kennedy
Chronic diseases in Canada 28 (3), 2008
272008
The system can't perform the operation now. Try again later.
Articles 1–20